 |
PDBsum entry 5g4r
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
5g4r
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Gsk6853, A chemical probe for inhibition of the brpf1 bromodomain.
|
 |
|
Authors
|
 |
P.Bamborough,
H.A.Barnett,
I.Becher,
M.J.Bird,
C.W.Chung,
P.D.Craggs,
E.H.Demont,
H.Diallo,
D.J.Fallon,
L.J.Gordon,
P.Grandi,
C.I.Hobbs,
E.Hooper-Greenhill,
E.J.Jones,
R.P.Law,
A.Le gall,
D.Lugo,
A.M.Michon,
D.J.Mitchell,
R.K.Prinjha,
R.J.Sheppard,
A.J.Watson,
R.J.Watson.
|
 |
|
Ref.
|
 |
Acs Med Chem Lett, 2016,
7,
552-557.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The BRPF (Bromodomain and PHD Finger-containing) protein family are important
scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A
selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a
cellular target engagement assay was recently described. Herein, we report the
optimization of this series leading to the identification of a superior BRPF1
inhibitor suitable for in vivo studies.
|
 |
|
|
|
|
 |